Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 17 Jun 2026 for Arrowhead Pharmaceuticals, INC.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
No signal scores available.
Matthew Gregory Cohen: trading record in brief
Our data holds just one disclosure by Matthew Gregory Cohen, dated 17 June 2026, reporting a share grant in Arrowhead Pharmaceuticals, Inc. Further filings will be added here. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Matthew Gregory Cohen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
11,882 sharesCommon StockSEC:0002141314-26-000004:0
1 of 1 declaration
